CN Stock MarketDetailed Quotes
301108 Tongling Jieya Biologic Technology
- 26.28
- +0.33+1.27%
Market Closed Dec 27 15:00 CST
2.13BMarket Cap37.92P/E (TTM)
26.35High25.80Low4.58KlotVolume25.83Open25.95Pre Close12.01MTurnover1.30%Turnover Ratio18.52P/E (Static)81.21MShares35.2252wk High1.15P/B926.06MFloat Cap20.8152wk Low31.14Limit Up35.24MShs Float95.97Historical High20.76Limit Down2.12%Amplitude20.81Historical Low0.36Dividend TTM26.22Avg Price1.51KlotAsk1.37%Div YieldTTM100Lot Size2.94KlotBid
Tongling Jieya Biologic Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 4.25%505.04M | 44.82%376.48M | 34.47%206.87M | -6.87%714.5M | -20.71%484.43M | -39.17%259.96M | -48.15%153.84M | -25.75%767.25M | -30.19%610.92M | -25.46%427.36M |
| Refunds of taxes and levies | 41.59%11.75M | 139.98%7.49M | 71.31%3.86M | -46.92%11.41M | -53.77%8.3M | -82.57%3.12M | -84.87%2.25M | -65.32%21.5M | -69.77%17.95M | -58.53%17.91M |
| Cash received relating to other operating activities | -55.20%4.64M | 51.55%5.53M | -32.25%2.79M | -49.99%8.59M | -54.24%10.35M | -79.47%3.65M | -78.79%4.12M | 15.62%17.17M | 207.96%22.61M | 225.65%17.76M |
| Cash inflows from operating activities | 3.65%521.42M | 46.03%389.51M | 33.27%213.52M | -8.86%734.5M | -22.78%503.07M | -42.39%266.73M | -51.60%160.22M | -27.40%805.91M | -30.83%651.48M | -25.55%463.03M |
| Goods services cash paid | 4.39%337.2M | 46.77%235.11M | 41.75%149.28M | 35.77%518.57M | 2.09%323.03M | -37.88%160.2M | -30.78%105.31M | -50.99%381.95M | -51.51%316.41M | -42.59%257.86M |
| Staff behalf paid | 7.65%57.06M | -1.66%39.61M | 17.59%22.73M | 11.88%79.42M | -3.06%53M | 4.91%40.27M | -3.83%19.33M | -18.44%70.99M | -18.62%54.67M | -20.02%38.39M |
| All taxes paid | -32.79%11.41M | 2.06%13.68M | 478.07%7.4M | -42.58%20.42M | -26.20%16.98M | -11.64%13.41M | -86.01%1.28M | 35.57%35.57M | -4.59%23M | -3.45%15.17M |
| Cash paid relating to other operating activities | 57.72%29.49M | 160.54%17.89M | -32.52%9.18M | 77.10%32.57M | 197.12%18.7M | -44.00%6.87M | -10.93%13.6M | 6.02%18.39M | -45.57%6.29M | 65.67%12.26M |
| Cash outflows from operating activities | 5.69%435.15M | 38.75%306.29M | 35.16%188.58M | 28.43%650.98M | 2.83%411.71M | -31.80%220.74M | -29.06%139.52M | -44.29%506.9M | -46.99%400.38M | -37.78%323.69M |
| Net cash flows from operating activities | -5.58%86.27M | 80.95%83.21M | 20.49%24.94M | -72.07%83.51M | -63.62%91.36M | -67.00%45.99M | -84.60%20.7M | 49.38%299.02M | 34.63%251.1M | 36.97%139.35M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 138.78%1.02B | 144.42%963M | 82.27%637.93M | 280.50%761M | 328.00%428M | 688.00%394M | --350M | --200M | --100M | --50M |
| Cash received from returns on investments | 72.74%22.25M | -26.42%1.75M | 548.03%5.72M | 62.16%4.84M | 579.80%12.88M | 247.33%2.38M | --882.67K | --2.99M | --1.9M | --685K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 8.09%315.57K | 121.87%267.78K | --81.25K | 8.07%380.84K | -37.69%291.94K | --120.69K | ---- | 205.83%352.4K | 306.60%468.5K | ---- |
| Cash inflows from investing activities | 136.76%1.04B | 143.38%965.02M | 83.46%643.73M | 276.82%766.22M | 330.99%441.17M | 682.28%396.5M | --350.88M | 176,371.68%203.34M | 88,738.54%102.36M | 197,793.97%50.69M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 14.27%79.43M | 270.49%78.41M | 437.17%34.12M | 184.35%85.05M | 189.25%69.51M | 50.74%21.16M | -28.24%6.35M | -58.79%29.91M | -62.40%24.03M | -73.29%14.04M |
| Cash paid to acquire investments | 22.44%1.31B | -4.59%955.07M | -0.17%589M | 39.32%1.07B | 137.64%1.07B | 186.00%1B | 136.00%590M | --770M | --450M | --350M |
| Cash outflows from investing activities | 21.94%1.39B | 1.11%1.03B | 4.49%623.12M | 44.74%1.16B | 140.26%1.14B | 180.78%1.02B | 130.38%596.35M | 931.01%799.91M | 587.85%474.03M | 532.38%364.04M |
| Net cash flows from investing activities | 50.66%-344.23M | 89.06%-68.46M | 108.40%20.61M | 34.36%-391.61M | -87.73%-697.73M | -99.67%-625.66M | 5.17%-245.47M | -670.07%-596.57M | -440.22%-371.67M | -444.58%-313.36M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --960K | --960K | --960K | --960K | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --960K | --960K | --960K | --960K | ---- | ---- | ---- |
| Cash received relating to other financing activities | 17.01%6.28M | 13.56%3.92M | --1.95M | -7.36%9.03M | --5.37M | --3.46M | ---- | --9.75M | ---- | ---- |
| Cash inflows from financing activities | -0.74%6.28M | -11.13%3.92M | 102.67%1.95M | 2.49%9.99M | --6.33M | --4.42M | --960K | -99.08%9.75M | ---- | ---- |
| Borrowing repayment | ---- | ---- | ---- | ---- | --5M | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | -34.92%29.16M | -33.53%29.16M | ---- | -33.33%40.6M | -26.43%44.81M | -27.96%43.88M | ---- | 23,026.94%60.91M | 23,026.94%60.91M | 23,868.79%60.91M |
| Cash payments relating to other financing activities | 58.72%23.59M | -3.88%13.95M | ---- | 161.08%7.83M | --14.86M | --14.51M | ---- | -87.21%3M | ---- | ---- |
| Cash outflows from financing activities | -18.43%52.75M | -26.17%43.11M | ---- | -24.21%48.44M | 6.18%64.67M | -4.14%58.39M | ---- | -7.00%63.91M | 34.56%60.91M | 51.31%60.91M |
| Net cash flows from financing activities | 20.35%-46.47M | 27.40%-39.19M | 102.67%1.95M | 29.01%-38.45M | 4.20%-58.35M | 11.39%-53.97M | --960K | -105.49%-54.16M | -34.56%-60.91M | -51.31%-60.91M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -82.51%300.94K | -52.17%1.05M | -449.92%-466.03K | -13.97%525.06K | -79.01%1.72M | 45.93%2.2M | 91.23%-84.75K | 116.87%610.32K | 607.36%8.2M | 179.29%1.51M |
| Net increase in cash and cash equivalents | 54.13%-304.14M | 96.30%-23.38M | 121.00%47.03M | 1.45%-346.02M | -282.62%-663M | -170.53%-631.45M | -78.45%-223.9M | -131.74%-351.11M | -344.64%-173.28M | -11,554.77%-233.41M |
| Add:Begin period cash and cash equivalents | -35.06%640.82M | -35.06%640.82M | -35.06%640.82M | -26.24%986.84M | -26.24%986.84M | -26.24%986.84M | -26.24%986.84M | 477.70%1.34B | 477.70%1.34B | 477.70%1.34B |
| End period cash equivalent | 3.97%336.68M | 73.74%617.44M | -9.84%687.85M | -35.06%640.82M | -72.19%323.84M | -67.82%355.39M | -37.08%762.94M | -26.24%986.84M | 285.10%1.16B | 372.76%1.1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
